John Hicks Co Ltd announces a new provision for clients in the centre of Cambridge.
John Hicks Co Ltd is now offering face to face consultations to clients within the heart of Cambridge.
Guardtech Group gearing up for busy Autumn exhibition schedule
Haverhill-based cleanroom construction specialists set to cover wide range of industries with stellar show line-up
Kuano raises £1.8M in seed funding to accelerate quantum drug discovery
Cambridge, UK, 12 September 2023: Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, announces the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors. The investment will facilitate further validation of Kuano’s…
Career change - a setback or an opportunity?
Career change can be seen as a setback and at the same time it can also be an incredible opportunity to re-evaluate what it is you really want from your career. There are several reasons why you might be facing a career change – you may have been laid off, or you might feel unhappy in your current role, or perhaps you simply want to do something new.
Orano Med and Orbit Discovery enter Collaboration to discover novel targeted radioligand therapies for cancer
Texas, US and Oxford, UK - Orano Med SAS, “Orano Med”, a biotechnology company developing Lead-212 (212Pb) Targeted Alpha Therapy against cancer, and Orbit Discovery Ltd, “Orbit”, a leader in the discovery of therapeutic peptide hits, announce that they have entered into a collaboration to discover specific Peptide Receptor Radionuclide Therapies against cancer cells and advance the development…
AudioTelligence launches crowdfunding campaign to meet demand for its hearing assistance device
AudioTelligence, a Cambridge audio software company, has launched a crowdfunding campaign in a bid to get its breakthrough hearing technology into the hands of those who struggle to hear in noisy environments.
Mills & Reeve advises on construction of advanced cancer research hospital
The Cambridge Cancer Research Hospital (CCRH) will be a 26,000m2 state of the art facility built in the heart of Cambridge.
All-inclusive service provided by the Epicentre, Haverhill allows universal genomics company MultiplAI to grow and move on
Its onwards and upwards for MultiplAI, a fast-expanding techbio company developing RNA-based, AI-driven, universal genomic screening for cardiovascular and other complex diseases, that has benefited from the flexible terms and business support offered by The EpiCentre in Haverhill.'
Arecor announces positive pre-IND meeting with FDA for novel ready-to-use medicine AT307 licensed to Hikma
Cambridge, UK - Arecor, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces further progress from Hikma in the development of ready-to-use ("RTU") injectable medicine AT307, following a recent positive pre-investigational new drug application (pre-IND) meeting between Hikma and the US Food and Drug Administration (FDA).
Essential building blocks for business success from founder of Axiom-e
Last term, Ken Dickson, the founder of Axiom-e, ran three versions of 'The Pillars of Business Success' course to audiences drawn from more than 20 countries. His first talk of this term will be at the Quadram Institute, a state-of-the-art facility for bioscience and clinical research, and endoscopy, based at the Norwich Research Park
What connects the world’s first wheelchair toddler with a world-famous Cambridge scientist?
What connects the world’s first wheelchair toddler with a world-famous Cambridge scientist?
Is it time for a health insurance black box?
electronRx writes...Telematics Insurance was marketed as a revolution in car insurance for the under-25s when Aviva first introduced the motor insurance policy in 2005. By agreeing to a GPS-tracked' Black Box' in their vehicle, young drivers could enjoy dramatically reduced premiums by proving they were safe and responsible on the road.
CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems
Cambridge, UK - CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, “LifeNet Health”, a non-profit, global leader in all-human research solutions, announces a strategic partnership to supply validated primary human cells for use with CN Bio’s PhysioMimix® OOC range of MPS.
Positive body image linked to better life satisfaction
Largest study of its kind also finds people in rural areas appreciate their bodies more
Revvity unveils next-generation preclinical imaging technologies to help scientists drive breakthrough discoveries
WALTHAM, Mass., Revvity, Inc. debuts its enhanced imaging portfolio designed to drive innovation across diverse applications in preclinical research with the launch of three systems.
Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows
Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow.
Wearable therapeutics that are changing the face of healthcare
Wearable technology has many advantages in healthcare. In diagnostics, wearables can provide always-on data collection, enabling faster and more accurate clinical decisi
Moving on up: Guardtech Group celebrate continued growth with switch to stunning new home
Cleanroom construction experts putting finishing touches on impressive new Guardtech House HQ in Haverhill.
TherageniX and University of Nottingham Awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration
London, UK, and Nottingham, UK - TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene…
Five ways to combat new job nerves when you hire
Studies show that 80% of people are nervous before starting a new job. Having spent time and money on the recruitment process, you'll want to make sure your new employees have a smooth onboarding process and hit the ground running as soon as possible.
Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering
BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division.
Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning
Cambridge, UK - Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, announces that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies.
CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer
Cambridge, UK, 30th August 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr. Tomasz Kostrzewski as Chief Scientific Officer.
Key human bladder cancer genes pinpointed in cats and dogs
Key bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding which of many mutations are the most important in the cancer’s development.